Drug Profile
Research programme: PIN1 inhibitors - Pfizer
Alternative Names: AG 122005Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Pin1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA
- 04 Aug 2009 Programme is in active development with Pfizer in the US